VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0951957
Sex: M
Age:
State: CO

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Gave a 16 year old male a COVID-19 injection; A spontaneous report was received from a pharmacist concerning a 16-year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) resulting in the event, gave a 16-year-old male a COVID-19 injection. The patient's medical history was not provided. No concomitant medications were reported. On an unknown date, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. On an unknown date, a nurse gave a 16-year-old patient a COVID-19 injection. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the event, gave a 16-year-old male a COVID-19 injection, was considered resolved.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age for mRNA-1273, lot # unknown. There were no reported AEs associated with this case of product administered to patient of inappropriate age.

Other Meds:

Current Illness:

ID: 0951958
Sex: F
Age: 16
State: IL

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Vaccine administered to pediatric patient; A spontaneous report was received from a nurse concerning a 16 year old female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and vaccine was administered to a pediatric patient. The patient's medical history was not provided. No relevant concomitant medications were reported. The patient received their first of two planned doses of mRNA-1273 (Lot #026L20A) on 31 Dec 2020, intramuscularly in the left arm, for prophylaxis of COVID-19 infection. On 31 Dec 2020, the Moderna vaccine was administered by error to a pediatric patient. The patient experiences no symptoms and was absolutely fine. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not reported. The event, vaccine was administered to a pediatric patient, resolved on 31 Dec 2020.; Reporter's Comments: This case concerns a 16-year-old female patient who received their first of two planned doses of mRNA-1273 (Lot 026L20A), reporting Product administered to patient of inappropriate age without any associated adverse events.

Other Meds:

Current Illness:

ID: 0951959
Sex: F
Age:
State: NY

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Given vaccine 12 hours after vial was punctured; Sore arm; A spontaneous report was received from a healthcare professional who was also a 37-years-old female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced product storage error and sore arm. The patient's medical history was not provided. Concomitant products included alprazolam. On 31 Dec 2020, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the left deltoid for prophylaxis of COVID-19 infection. On 31 Dec 2020, the patient experienced product storage error when she received a dose of vaccine taken from a vial that had been punctured 12 hours before. She also experienced a sore arm. Action taken with mRNA-1273 in response to the events was not provided/unknown. The outcome of the event, product storage error, was resolved on 31 Dec 2020. The outcome of the event, sore arm, was unknown.; Reporter's Comments: This report refers to a case of product storage error for mRNA-1273 and concerns a 37 year-old, female patient, who experienced the event of pain in extremity. The event occurred the same day after the first and last dose of mRNA-1273 vaccine administration. Based on the current available information and temporal association between the use of the product and the start of the event, a causal relationship cannot be excluded and the event is assessed as possibly related.

Other Meds: XANAX

Current Illness:

ID: 0951961
Sex: M
Age: 55
State: TX

Vax Date: 12/27/2020
Onset Date: 12/27/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Very hot. Warm to touch; Large area of redness around his arm; Doubt if the shot was done intramuscularly; A spontaneous report was received from a nurse concerning a 55 year-old, male patient who received Moderna's COVID-19 vaccine and experienced a large area of redness around his arm, Very hot. Warm to the touch, and doubt if the shot was done intramuscularly. The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included regular medication for cholesterol, triglycerides and antidepressant. On 27 Dec 2020, the patient received their first of two planned doses of mRNA-1273 in their left arm for prophylaxis of COVID-19 infection. On 04 Jan 2021, the patient experienced a very large area of redness around his arm. Very hot. Warm to touch. The reporter noted that the person administering the vaccine did not have the right technique, and they doubt if the shot was done intramuscularly. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was unknown. The events large area of redness around his arm and Very hot. Warm to the touch were considered not recovered/not resolved. The event doubt if the shot was done intramuscularly was considered recovered/resolved on 27 Dec 2020.; Reporter's Comments: This report refers to a case of product administration error for mRNA-1273 and concerns a 55 year-old, male patient, who experienced the events of injection site warmth and erythema. The event occurred 9 days after the first and only dose of mRNA-1273 vaccine administration. Based on the current limited available information and temporal association between the use of the product and the start of the events, a causal relationship cannot be excluded and the events are assessed as possibly related.

Other Meds:

Current Illness: Cholesterol; Triglycerides

ID: 0951962
Sex: U
Age:
State: IL

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: 17 year old received the vaccine; A spontaneous report was received from a pharmacist concerning a 17-year-old patient who received Moderna's COVID-19 vaccine (mRNA-1273) resulting in the event, 17 year old received the vaccine. The patient's medical history was not provided. No concomitant medications were reported. On 04 Jan 2021, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the deltoid for prophylaxis of COVID-19 infection. On 04 Jan 2021, the 17-year-old patient received the mRNA-1273 vaccine. The patient did not experience any symptoms and did not receive any treatments. Action taken with mRNA-1273 in response to the event was unknown. The event, 17 year old received the vaccine, was considered resolved on 04 Jan 2021.; Reporter's Comments: This report refers to a case of 17- year-old female patient who received the mRNA-1273 vaccine (Inappropriate age at vaccine administration) Lot # was not provided. There were no reported AEs associated with this case of Incomplete dose administered

Other Meds:

Current Illness:

ID: 0951963
Sex: F
Age:
State: RI

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: A good portion of the vaccine ran on arm; A good portion of the vaccine ran on arm; The needle and the syringe separated; A spontaneous report was received from a nurse concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the events, the needle and the syringe separated and a good portion of the vaccine on arm. The patient's medical history was not provided. No relevant concomitant medications were reported. On 29 Dec 2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. On 29 Dec 2020, during vaccine administration, the needle and syringe separated and a good portion the vaccine ran down the patient's arm. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The events, the needle and the syringe separated and a good portion of the vaccine ran on arm, were considered resolved on 29 Dec 2020.; Reporter's Comments: This report refers to a case of out of incorrect dose administered, exposure via skin contact and device connection issue for mRNA-1273, lot # unknown. There were no reported AEs associated with this case of incorrect dose administered, exposure via skin contact and device connection issue.

Other Meds:

Current Illness:

ID: 0951964
Sex: M
Age: 45
State: GA

Vax Date: 12/30/2020
Onset Date: 12/30/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Part of face a little paralyzed; Part of face numb; Chills; Tiredness; A spontaneous report was received from a health care professional, who was a 45 year-old patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced chills, tiredness, part of face numb, and part of face a little paralyzed. The patient's medical history included type 1 diabetes. No relevant concomitant medications were reported. On 30 Dec 2020, the patient received the first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. On 30 Dec 2020, the evening after vaccine administration, the patient experienced chills and tiredness. On 31 Dec 2020 the patient woke up with his face numb and a little paralyzed. At the time of reporting, the patient mentioned that the numbness and paralysis on his face had been like that for various days and was still ongoing. Treatment for the event was not provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events, chills and tiredness, was unknown. The outcome of the events, part of face numb and part of face a little paralyzed, was considered not resolved.; Reporter's Comments: This case concerns a 45 year old male patient with medical history of type I diabetes, who experienced a serious unexpected event of Facial paralysis, a NS unexpected event of Hypoaesthesia, and NS expected events of Chills and Fatigue. The events of Chills and Fatigue occurred on the same day when the patient received the first of two planned doses of mRNA-1273. The events of Facial paralysis and Hypoaesthesia occurred the next day of administration of mRNA-1273. Very limited information regarding the events has been provided at this time. Based on temporal association between the use of the product and the onset of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness: Type 1 diabetes mellitus

ID: 0951965
Sex: M
Age: 84
State:

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 01/18/2021
Hospital: Y

Lab Data:

Allergies:

Symptoms: Muscle pull; A spontaneous report was received from a physician, concerning an 84-year-old patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced muscle pull. The patient's medical history was not provided. Concomitant medications included blood thinners. On 31 Dec 2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. On 31 Dec 2020, on the same day of vaccine administration, the patient experienced severe pain in the arm, shoulder, and front of his chest into his back. He was taken to the emergency room (ER) where he was diagnosed with a muscle pull and was admitted to the hospital for one night. Treatment for the event included 500mg paracetamol. At the time of the report, the patient was still experiencing symptoms. Action taken with mRNA-1273 in response to the event was not reported. The outcome of the event, muscle pull, was considered not resolved.; Reporter's Comments: Company comment: This case concerns an 84-year-old male patient, who experienced unexpected serious event of muscle pull. The event occurred 1 days after the administration of the first and only dose of the Moderna's COVID-19 vaccine (mRNA-1273). Based on the known cause for muscle pull which is mostly due to an overstretched or torn muscle, the event is assessed as unlikely related to mRNA-1273 administration.

Other Meds:

Current Illness:

ID: 0951966
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Vaccinated with shaken vaccine; Pain at the injection site; A spontaneous report was received from a pharmacist concerning a 24 year-old female patient who received Moderna's COVID-19 vaccine and experienced vaccinated with shaken vaccine and pain at the injection site. The patient's medical history was not provided. No relevant concomitant medications were reported. On an unknown date, the patient received their first of two planned doses of mRNA-1273 for prophylaxis of COVID-19 infection. On 04 Jan 2021, the reporter stated that the technician shook the vial while administering the vaccine on an unknown date.They also reported that symptoms included pain at the injection site. No treatment information was provided. Action taken with the second dose of mRNA-1273 in response to the event was not reported. The event, vaccinated with shaken vaccine was considered resolved. The outcome of the event, pain at the injection site, was unknown.; Reporter's Comments: This case concerns a 24 year-old female, who experienced a non-serious expected event of injection site pain and wrong technique in product usage process. The event occurred soon (exact time not provided) after first dose of mRNA-1273, lot # unknown. Based on the current available information and temporal association between the use of the product and the start date of the event, for the event of injection site pain a causal relationship cannot be excluded. There was no reported AE associated with this case of wrong technique in product usage process.; Sender's Comments: US-MODERNATX, INC.-MOD-2021-002858: US-MODERNATX, INC.-MOD-2021-002872: US-MODERNATX, INC.-MOD-2021-002862:

Other Meds:

Current Illness:

ID: 0951967
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Vaccinated with shaken vaccine; Pain at the injection site; Mild fever; A spontaneous report was received from a pharmacist concerning a 56-year old, male patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced vaccinated with shaken vaccine, pain at the injection site, and mild fever. The patient's medical history was not provided. No relevant concomitant medications were reported. On an unknown date, approximately 0 days prior to the onset of the event, vaccinated with shaken vaccine, and 1 day prior to the onset of the events, pain at the injection site, and mild fever the next day, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. During vaccine administration, the patient noticed the vaccinating technician shook the vial while administering the vaccine. One day after vaccination, the patient experienced pain at the injection site and mild fever. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The event, vaccinated with shaken vaccine, was considered resolved on an unknown date. The outcome of the events, pain at the injection site and mild fever were unknown.; Reporter's Comments: Company comment: This case concerns a 56-year old, male subject, who experienced a non-serious expected event of Injection site pain and pyrexia, and non-serious unexpected event of wrong technique in product usage process. The event of injection site pain and pyrexia occurred 1 days after the first dose of mRNA-1273, lot # unknown. Treatment details not available. Very limited information regarding this event/s has been provided at this time. Based on temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: US-MODERNATX, INC.-MOD-2021-002862: US-MODERNATX, INC.-MOD-2021-002848: US-MODERNATX, INC.-MOD-2021-002858: US-MODERNATX, INC.-MOD-2021-002872: US-MODERNATX, INC.-MOD-2021-002858:

Other Meds:

Current Illness:

ID: 0951968
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Vaccinated with shaken vaccine; pain at the injection site; A spontaneous report was received from a pharmacist concerning a 57-year-old, male patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced vaccine that was shaken and pain at the injection site. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. The patient received their first of two planned doses of mRNA-1273 on an undisclosed date intramuscularly for prophylaxis of COVID-19 infection. On 04 Jan 2021, the reporter stated that on a undisclosed date, the technician shook the vial while administering the vaccine to the patient. They also reported that symptoms included pain at the injection site. No treatment information was provided Action taken with mRNA-1273 in response to the events, the technician shook the vial while administering the vaccine and pain at the injection site, was not provided. The events, the technician shook the vial while administering the vaccine was considered recovered/resolved. The outcome of the events, pain at the injection site was not reported.; Reporter's Comments: This case concerns a 57-year-old male patient who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Out of specification product use and Injection site pain. Based on the known safety profile and temporal association between vaccination and onset of the event, a causal relationship cannot be excluded, and the event Injection site pain is considered possibly related to the vaccine.; Sender's Comments: US-MODERNATX, INC.-MOD-2021-002858: US-MODERNATX, INC.-MOD-2021-002848: US-MODERNATX, INC.-MOD-2021-002872:

Other Meds:

Current Illness:

ID: 0951969
Sex: U
Age:
State: NC

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Incomplete dose; A spontaneous report was received from a pharmacist concerning an unidentified patient who received Moderna's COVID-19 Vaccine (mRNA-1273)and experienced incomplete dose. The patient's medical history was not provided. No relevant concomitant medications were reported. On 04 Jan 2021, approximately 0 days prior to the onset of the event, the patient received their first/second of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. On 04 Jan 2021, the vaccinating pharmacist reported when they pulled the needle of the syringe from the patient's arm, it seemed like the entire dose of vaccine came out. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not reported. The event, while pulling the needle of the syringe from patient's arm, it seems the entire dose of the vaccine came out, was considered resolved on 04 Jan 2021.; Reporter's Comments: This report refers to the case of a patient who during administration of Moderna's mRNA-1273 vaccine (lot # unknown, Exp. Unknown) when they pulled the needle of the syringe from the patient's arm, it seemed like the entire dose of vaccine came out. There were no reported AEs associated with this case of when they pulled the needle of the syringe from the patient's arm, it seemed like the entire dose of vaccine came out.

Other Meds:

Current Illness:

ID: 0951970
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Vaccinated with shaken vaccine; pain at the injection site; A spontaneous report was received from a pharmacist concerning a 36 year-old female patient who received Moderna's COVID-19 vaccine and experienced the technician shook the vial while administering the vaccine and pain at the injection site. The patient's medical history was not provided. No relevant concomitant medications were reported. On an unknown date, the patient received their first of two planned doses of mRNA-1273 in the right arm for prophylaxis of COVID-19 infection. On 04 Jan 2021, the reporter stated that the technician shook the vial while administering the vaccine. They also reported that symptoms included pain at the injection site. No treatment information was provided. Action taken with the second dose of mRNA-1273 in response to the event was not reported. The event, technician shook the vial while administering the vaccine was considered resolved. The outcome of the event, pain at the injection site, was unknown.; Reporter's Comments: This report refers to a case of Out of specification product use for mRNA-1273 and concerns a 36 year-old, female patient, who experienced the event of injection site pain. The event occurred the same day after the first and last dose of mRNA-1273 vaccine administration. Based on the current available information and temporal association between the use of the product and the start of the event, a causal relationship cannot be excluded and the event is assessed as possibly related.; Sender's Comments: US-MODERNATX, INC.-MOD-2021-002862: US-MODERNATX, INC.-MOD-2021-002858: US-MODERNATX, INC.-MOD-2021-002848:

Other Meds:

Current Illness:

ID: 0951971
Sex: F
Age: 36
State: MA

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Administered vaccine after 8 hours of refrigeration instead of 6 hours; A spontaneous report was received from a physician concerning a 36-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and was administered vaccine after 8 hours of refrigeration instead of 6 hours. The patient's medical history was not provided. No relevant concomitant medications were reported. On 31 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot number: 025J20A, Exp. date: 25 May 2021) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection. On 31 Dec 2020, the patient was administered with a vaccine dose that had been stored in the refrigerator for 8 hours due to a misunderstanding with the instructions. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not reported. The outcome of the event, administered vaccine after 8 hours of refrigeration instead of 6 hours, was considered resolved on 31 Dec 2020.; Reporter's Comments: This report refers to a case of 36- year-old female patient who experienced non-serious unexpected event of patient was administered vaccine after 8 hours of refrigeration instead of 6 hours.(Expired product administered) for mRNA-1273, lot # 025J20A, Exp. date: 25 -May -021. There were no reported AEs associated with this case of administered vaccine after 8 hours of refrigeration instead of 6 hours.

Other Meds:

Current Illness:

ID: 0951972
Sex: F
Age:
State: KY

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I felt quite sick, like I had the flu; became very lightheaded and dizzy; passed out; felt quite sick; This is a spontaneous report from a contactable consumer (patient). A 69-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 at 12:30 at single dose in left arm for covid-19 immunization. Medical history included R.A.D., osteopenia, migraine with aura, the patient had previously suffered episodes of vasal vagal syncopy when she got the flu or other severe illnesses, and the patient was diagnosed with COVID-19 prior to vaccination. Concomitant medication included atenolol, atorvastatin, azelastine, and fluticasone. The patient previously took gramicidin, neomycin sulfate, polymyxin b sulfate (NEOSPORIN) and experienced allergies. The morning after receiving the vaccine, she felt quite sick, like she had the flu. When she got up from bed and went to the bathroom to urinate, she became very lightheaded and dizzy. She attempted to return to bed, but passed out on the bedroom floor before she could get to the bed, and seized while she was unconscious. Once she came to, she was helped to bed and, after about 90 minutes, felt much better, and got up, and ate food and had coffee. All events occurred at 07:30 AM on 09Jan2021. All events were reported as non-serious by reporter. The patient did not receive treatment for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient has not been tested for COVID-19 since the vaccination. The outcome of the events was resolved in Jan2021. Information on the lot/batch number has been requested.

Other Meds: ; ; ;

Current Illness:

ID: 0951973
Sex: F
Age:
State: VA

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Blacked out; Fainted; Felt very unwell; Nauseous; Chills; Fell; Knocked out, hit her nose, started to bleed; Humongous scar on her nose; In her hand there's a rash with different dots/red; She has petechiae/rash on the forearm; hit her face; knocked out, hit her nose; This is a spontaneous report from a contactable physician. This physician reported that a 30-year-old female patient (daughter) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced blacked out, fainted, felt very unwell, nauseous, chills, fell, knocked out, hit her nose, started to bleed, humongous scar on her nose, in her hand there's a rash with different dots/red, she has petechiae/rash on the forearm, all on an unspecified date in Jan2021. The Caller wanted information on side effects specifically looking at platelet or clotting or bleeding issues. Her daughter, (female, age 29 date of birth) received the 2nd dose of Pfizer vaccine, received it at the (State name), last night. She felt very unwell, nauseous, chills, and then blacked out, fell, knocked out, hit her nose, started to bleed; fainted and hit her face, didn't stop bleeding for 2 hours. There's a humongous scar on her nose. It took 2 hours to stop bleeding. She's going to urgent care today. Her daughter was healthy, yesterday was 2nd dose. In her hand, there's a rash with different dots/red. She has petechiae/rash on the forearm. Thankfully it (bleeding) did stop. The outcome of events for 'knocked out, hit her nose, started to bleed' was resolved on an unspecified date, for other events was unknown. The case was reported as non-serious. Information on the Batch/Lot number has been requested.; Sender's Comments: Based solely on a chronological association a causal relationship between events blacked out and fainted and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), cannot be completely excluded. The case will be reevaluated should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0951974
Sex: F
Age:
State: PA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Muscle, joint and back aches; Muscle, joint and back aches; Muscle, joint and back aches; This is a spontaneous report from a contactable nurse (patient). A 34-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231, expiration date not reported), via an unspecified route of administration on the left arm on 08Jan2021 15:00 at single dose for COVID-19 immunization. Medical history included appendicectomy in 2000. Concomitant medication included alprazolam (XANAX), linaclotide (LINZESS), fluoxetine (FLUOXETINE), buprenorphine hydrochloride, naloxone hydrochloride (BUPRENORPHINE/NALOXONE). The patient received first dose of bnt162b2 (lot number and expiration date not reported) on an unspecified date for COVID-19 immunization. The patient experienced muscle, joint and back aches on 09Jan2021 22:00. No treatment was given in response to the events. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Outcome of the events was unknown.

Other Meds: XANAX; LINZESS; ; BUPRENORPHINE/NALOXONE

Current Illness:

ID: 0951975
Sex: F
Age:
State: OK

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Redness, itching, hives on and around injection site; Redness, itching, hives on and around injection site; hives on and around injection site approximately 5 hours; This is a spontaneous report from a contactable nurse who reported for herself, a 37-year-old female patient who received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date unknown) at the Workplace clinic, intramuscular in the right arm on 08Jan2021 at 16:15 at a single dose for COVID-19 immunization. The patient's medical history was not reported. Patient had no COVID prior to vaccination, and was not COVID tested post vaccination. The patient was not pregnant. There were no concomitant medications. The patient previously took and had known allergies to morphine and Hep B vaccine preservative. The patient previously received the first dose of BNT162B2 (unknown lot number) on 18Dec2020 at 11:45 AM, at 36 years of age, via intramuscular in the right arm for COVID-19 immunization. On 08Jan2021 at 21:15, the patient experienced redness, itching, hives on and around injection site approximately 5 hours after 2nd dose, still present 2 days later. No treatment was received for the events. The outcome of the events was recovering. No follow-up attempts are possible; Information on lot/batch cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0951976
Sex: M
Age:
State: MO

Vax Date: 12/21/2020
Onset Date: 01/09/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Painful and enlarged left axillary lymphadenopathy; Painful and enlarged left axillary lymphadenopathy; This is a spontaneous report from a contactable physician. A 39-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number EK5730, via an unspecified route of administration on 21Dec2020 08:15 at a [SINCLE DOSE] and (lot number EK9231),via an unspecified route of administration on 08Jan2021 10:30 at a [SINCLE DOSE] for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously took aspirin (e.c.) and experienced drug hypersensitivity. On 09Jan2021, the patient experienced painful and enlarged left axillary lymphadenopathy. The outcome of the event was not recovered.

Other Meds:

Current Illness:

ID: 0951977
Sex: F
Age:
State: HI

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; Nausea; pain at the injection site; Fever; Chills; body ache; Fatigue; tingling/numbness at injection site; tingling/numbness at injection site; shoulder stiffness; altered taste; This is a spontaneous report from a contactable physician (patient). A 29-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscularly at left arm on 08Jan2021 at 11:00AM at a single dose (dose number: 2) for COVID-19 immunization. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization and experienced swelling at injection site, inflammation around injection site. No Known allergies (allergies to medications, food, or other products) and no other medical history. It was unknown if the patient was pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Facility where the most recent COVID-19 vaccine was administered was at hospital. The patient experienced headache, nausea, pain at the injection site, fever/chills, body ache, fatigue, tingling/numbness at injection site, shoulder stiffness, altered taste - after 2nd dose. Events with start date on 08Jan2021 at 11:30 PM. The events were reported as non-serious. No treatment received for events. The outcome of events was not resolved. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0951978
Sex: F
Age:
State: CO

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swelling at the injection site; Pain at the injection site; burning upon administration; Redness at the injection site; Warmth at the injection site; This is a spontaneous report from a contactable healthcare professional (patient). A 31-year-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EJ1284), via an unspecified route of administration in left arm, on 04Jan2021 at 12:00, at a single dose, COVID-19 immunization. The patient's medical history included polycystic ovarian syndrome (PCOS) and fish allergy. The patient's concomitant medications included Curcuma longa (TURMERIC), probiotics, and unspecified multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The most recent COVID-19 vaccine was administered in a hospital. On 04Jan2021 at 12:00 PM, the patient experienced swelling, pain, redness, and warmth at the injection site lasting for 3 days. It was burning upon administration. The events were considered non-serious. No treatment was received for the adverse events. Since the vaccination, the patient has not been tested for COVID-19. The patient recovered from the events on 07Jan2021. No follow-up attempts are possible. No further information is expected.

Other Meds: TURMERIC [CURCUMA LONGA];

Current Illness:

ID: 0951979
Sex: F
Age:
State: IN

Vax Date: 01/07/2021
Onset Date: 01/01/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Name: HR; Result Unstructured Data: Test Result:60s-70s; Comments: baseline; Test Name: HR; Result Unstructured Data: Test Result:110s120s; Comments: My baseline hr runs in 60s-70s, but was in 110s120; Test Name: HR; Result Unstructured Data: Test Result:80s; Comments: HR still elevated in 80s overnight

Allergies:

Symptoms: fist dose on 21Dec2020, second dose on 07Jan2021; pain and stiffness radiating from injection site all the way down arm,into breast, and middle of back; pain and stiffness radiating from injection site all the way down arm,into breast, and middle of back; pain and stiffness radiating from injection site all the way down arm,into breast, and middle of back; Started having chills; Severe headache; collapsed on the way back to bathroom and was unable to get up for about 20 minutes; tachycardia; extremely fatigued entire day; This is a spontaneous report from a contactable Pharmacist who reported for herself. A 30-year-old female patient received her second dose of BNT162B2 (Pfizer/ BioNTech Covid-19 vaccine, lot number Ej1685) at a single dose at 09:45 AM 07Jan2021 at left arm for Covid-19 immunization in a hospital. The patient had her first dose of Pifzer Covid-19 vaccine on 21Dec2020 at 12:00 PM at left arm, and experienced very mild reactions which included mild pain at injection site and runny nose/sneezing day after vaccine. The paitent had a medical hisotry of rash to penicillin as a child. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to her first dose of Pfizer COVID vaccine. In the evening of second vaccine (around 17:00), pain and stiffness radiated from injection site all the way down arm, into breast, and middle of back. She started having chills. Around 10 hours after dose chills became somewhat violent despite being under 4 blankets. Severe headache also started. In the middle of the night to go to bathroom, she collapsed on the way back and was unable to get up for about 20 minutes. She also suffered from tachycardia overnight. her baseline heart rate runs in 60s- 70s, but was in 110s-120s (based on Apple Watch monitoring). Day after vaccine, she was extremely fatigue entire day and spent all but a few hours in bed. Arm pain mostly gone. Headache was very strong and persistent through the day. On second night chills not as bad but still occurred overnight. HR still elevated in 80s overnight. Morning of day 2 still had headache and fatigue. The patient did not receive any treatment for the events. The outcome of collapse and unable to get up for 20minutes, pain and stiffness radiating from injection site all the way down arm,into breast, and middle of back was resolved, chills and tachycardia was resolving, headache, fatigue was not resolved. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The reporter considered that the events was non-serious.; Sender's Comments: Based on a chronological temporal association and known BNT162B2 vaccine safety profile, causality between events fainting, violent chills and severe headache and BNT162B2 ((Pfizer/ BioNTech Covid-19 vaccine) cannot be completely excluded. The case will be reevaluated should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0951980
Sex: F
Age:
State: CA

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: BNT162B2 first dose 18Dec2020, second dose 06Jan2021; Severe sharp headache behind left eye; Severe nausea (but could be from headache).; Possible migraine; Mild photophobia; Mild photophobia; This is a spontaneous report from a contactable Physician who reported for herself. A 51-year-old female patient received her second single dose of BNT162B2 (Pfizer/ BioNTech Covid-19 vaccine, lot number EL3249) at left arm at 17:30 06Jan2021 for Covid-19 immunization in a hospital. She had her first injection at 07:15 PM 18Dec2020 and experienced mild photophobia within 5-10 min. The patient had a medical histroy of allergic rhinitis and was allergic to cashews. Concomitant medications included fexofenadine, colecalciferol (VITAMIN D), cyanocobalamin (VITAMIN B12). The patient did not receive any other vaccines within 4 weeks prior to her first COVID vaccine. Within 5-10 minutes of 2nd injection, the patient had mild photophobia (also after 1st injection but patient did not recognize the symptom at that time). About 20 hours after 2nd injection, the patient developed severe sharp headache behind left eye, severe nausea (but could be from headache/ possible migraine). The patient stated that she had no prior history of migraines or frequent headaches. Three days after 2nd dose, the patient's lingering intermittent mild left-sided headache persisted. The patient self-administered OTC oral analgesics. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events headache, nausea, migraine, photophobia at the time of last observation was resolving. The patient considered that the events were non-serious.

Other Meds: ; VITAMIN D [COLECALCIFEROL]; VITAMIN B12 [CYANOCOBALAMIN]

Current Illness:

ID: 0951981
Sex: F
Age:
State: WA

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; This is a spontaneous report from a non-contactable Other Health Professional (patient). A 25-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: Ej1685, expiration date was not reported), via an unspecified route of administration in the right arm, on 09Jan2021 08:45 at a single dose for COVID-19 immunization. Medical history included drug known allergies to penicillin (hives). Concomitant medication included bupropion, hydroxyzine, propranolol, levonorgestrel (MIRENA) and OCP (unspecified). Historical vaccine included first dose of PFIZER BIONTECH COVID 19 VACCINE (lot number: Ej1685) via an unspecified route of administration in the right arm, on 19Dec2020 08:30 at a single dose for COVID-19 immunization. The patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She was not diagnosed with COVID-19 prior to vaccination and she has not been tested for COVID-19 post vaccination. The patient experienced headache on 09Jan2021 at 09:30 PM with outcome of not recovered. Therapeutic measures were taken as a result of headache with Tylenol. No follow up attempts are possible. No further information is expected.

Other Meds: ; ; ; MIRENA

Current Illness:

ID: 0951982
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Circulation felt impeded; middle finger turned purple; it happened in the right hand middle finger, got red, then swelled; it happened in the right hand middle finger, got red, then swelled; This is a spontaneous report from a contactable consumer via the Medical Information Team. A female patient of an unspecified age started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from an unspecified date at a single dose for an unspecified indication. The patient's medical history and concomitant medications were not reported. It was reported that the patient received the first dose and 9 days later her middle finger turned purple. It lasted for 2 days and faded away. Last night, it started up again in one middle section in the middle segment of the middle finger. Circulation felt impeded, it happened in the right hand middle finger, got red, then swelled and then got purple. when she woke up, color came back and everything felt normal. The outcome of the events was recovered on an unspecified date. Information about Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0951983
Sex: F
Age:
State:

Vax Date: 12/18/2020
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Recieved dose #1 of Pfizer Covid vaccine on 18Dec2020 with very mildly sore arm at injection site.; This is a spontaneous report from a non-contactable nurse. A 28-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK798), intramuscular in the right arm on 18Dec2020 13:45 at a single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included ergocalciferol (VIT D), ethinylestradiol, norethisterone (NORTREL [ETHINYLESTRADIOL;NORETHISTERONE]). The patient previously took and had allergies with Phenergan. The patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination nor was she tested for COVID-19 post vaccination. The patient received first dose of Pfizer Covid vaccine on 18Dec2020 with very mildly sore arm at injection site on an unspecified date with outcome of recovering. The event was reported as non-serious. No treatment received for the event. No follow up attempts are possible. No further information is expected.

Other Meds: VIT D; NORTREL [ETHINYLESTRADIOL;NORETHISTERONE]

Current Illness:

ID: 0951984
Sex: F
Age:
State: MT

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: Fever; Result Unstructured Data: Test Result:103 Fahrenheit; Comments: At hour 8, spiked fever to 103 degrees Fahrenheit. Fever stayed greater then 100 degrees with spikes to 103 for over 48 hours

Allergies:

Symptoms: At hour 8, spiked fever to 103 degrees fareinheit; Also have had intense chills, aches, headache, dizziness and mild nausea with loss of appetite.; Also have had intense chills, aches, headache, dizziness and mild nausea with loss of appetite.; Also have had intense chills, aches, headache, dizziness and mild nausea with loss of appetite.; Also have had intense chills, aches, headache, dizziness and mild nausea with loss of appetite.; Approximately 6 hours after injection felt body aches and chills.; Approximately 6 hours after injection felt body aches and chills.; This is Spontaneous report from a Non-contactable Nurse. A 28-years-old female (no pregnant) patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3246), intramuscular on 08Jan2021 09:00 at the second single dose at Arm Right for covid-19 immunisation. Medical history included birth control. Concomitant medication included vitamin d3 (VITAMIN D3), ethinylestradiol, norethisterone (NORTREL) for birth control, and multivitamin. The patient previously took phenergan and experienced drug hypersensitivity, the first bnt162b2 on 18Dec2020 and experienced very mildly sore arm at injection site. On 08Jan2021 received dose #2. Approximately 6 hours after injection felt body aches and chills. On 08Jan2021 17:30, spiked fever to 103 degrees Fahrenheit. Fever stayed greater then 100 degrees with spikes to 103 for over 48 hours despite usage of antipyretics and cold compresses. Also have had intense chills, aches, headache, dizziness and mild nausea with loss of appetite. No local reaction at site noted. The patient did not received treatment for other events, except for Fever. Outcome of events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: VITAMIN D3; NORTREL [ETHINYLESTRADIOL;NORETHISTERONE]

Current Illness:

ID: 0951985
Sex: F
Age:
State: CA

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Name: headache pain; Result Unstructured Data: Test Result:7 out of 10

Allergies:

Symptoms: Headache/headache got worse and worse; This is a spontaneous report from a contactable consumer (patient). This consumer reported similar events for two patients (herself and co-worker). This is the first of two reports. A 61-year-old female patient received the second dose of bnt162b2 (BNT162B2, lot number: EJ1686, expiry date: unknown), intramuscular, on 06Jan2021 13:30 at a single dose on left arm for COVID-19 immunization. The vaccine was administered at a hospital. It was also reported that she received the vaccine at a military facility. There were no additional vaccines administered on same date of bnt162b2. Medical history included high blood pressure diagnosed about a month ago (Dec2020) and ongoing, and glaucoma from an unspecified date (diagnosed when she was 15 years old) and ongoing. Concomitant medications included losartan (Manufacturer: Lupin, 50 mg tablet) for high blood pressure, venlafaxine ER (Manufacturer: Aurobindo, 150 mg Prolonged-release capsule) as anti-depressant, latanoprost (Manufacturer: Sandoz, 0.005 %) for glaucoma, and brimonidine tartrate, timolol maleate (COMBIGAN, Manufacturer: Allergan) for glaucoma; all were from unspecified dates and ongoing. The patient previously received the first dose of bnt162b2 (BNT162B2, lot number: EH9699), intramuscular, on 19Dec2020 at a single dose on left arm for COVID-19 immunization; there was no adverse event following this vaccination. The patient experienced headache on 06Jan2021 at 11:45 am (As reported, pending clarification). The patient reported that she did not have anything with the first dose. She got the second dose of the Pfizer Covid Vaccine on 06Jan2021 at 13:30. She started getting headache at 11:45 am (as reported) but she didn't think much of it. On 07Jan2021, she had a headache and she took two Tylenol and then went to sleep. She woke up around midnight that night and her headache got a little bit worse, so she took two Tylenol again and fell asleep. In the morning of 08Jan2021, around 2:30 am her headache got worse and worse, and she took three Tylenol. Her headache was still there but it was not enough to go to the emergency room or anything. She panicked on Thursday (07Jan2021) since her headache was still there; her headache was still lingering but it was going away. Her headache pain was at 7 out of 10 on an unspecified date. She stated that she was supposed to work at the time of report, but she called out of work due to her headache. Therapeutic measures were taken as a result of the headache and included treatment with Tylenol 500 mg (lot number: DFE3060A, expiration date: Apr2022). The adverse event did not require a visit to Emergency Room or Physician office. Outcome of the event was recovering.

Other Meds: ; ; ; COMBIGAN

Current Illness: Blood pressure high (diagnosed about a month ago); Glaucoma (diagnosed when she was 15 years old)

ID: 0951986
Sex: F
Age:
State: TN

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: awakes around 3 am with severe itching on my legs; awakes around 3 am with severe itching on my legs; huge rash on her legs front and back but not on torso only on neck; This is a spontaneous report from a contactable nurse (patient) reported that a 58-year-old female patient received the second dose BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on 08Jan2021 at a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient had no known allergies. Concomitant medication included omeprazole magnesium (PRILOSEC). The patient did not have COVID-19 prior to vaccination. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, EL1284) on 18Dec2020 at 6:00 AM on the right arm. The patient reported that on a cupid days (as reported) after vaccine, she broke out in huge whips and rash from her face to the bottom of torso, it did this twice, so severe had she had to be put on a dose pack. The patient then received her second dose 08Jan2021 and awakes around 3 am with severe itching on my legs and this time huge rash on my legs front and back but not on torso only on neck on 08Jan2021 (as reported). The patient took Benadryl. The outcome of the events pruritus and rash was recovered while the outcome of the event was unknown. The patient had not been tested for COVID-19 post vaccination. Information on the lot/ batch number has been requested.

Other Meds: PRILOSEC [OMEPRAZOLE MAGNESIUM]

Current Illness:

ID: 0951987
Sex: F
Age:
State: VA

Vax Date: 12/21/2020
Onset Date: 01/05/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash was pruritic and diffuse/one day later became less itchy and more macular papular in nature; Developed urticarial rash; Rash was pruritic and diffuse, spread to extremities, back, trunk and face; This is a spontaneous report from a contactable physician (patient). A 29-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as COVID-19 vaccine; lot number: EH9898; expiration date: unknown), intramuscular left arm on 21Dec2020 16:00 at a single dose for covid-19 vaccination. Medical history included depression and anxiety. The patient has no known allergies. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included ethinylestradiol, ferrous fumarate, norethisterone acetate (JUNEL FE) and escitalopram oxalate (LEXAPRO). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the most recent COVID-19 vaccine in a hospital on 21Dec2020 04:00 PM. The patient developed urticarial rash about 2 weeks (05Jan2021 07:00 AM) after receiving vaccine. The rash was pruritic and diffuse that spread to extremities, back, trunk and face. About one day later (06Jan2021), it became less itchy and more macular papular in nature. No other symptoms. No airway swelling. The events were considered as non-serious. The patient has not been tested for COVID-19 since the vaccination. The patient did not received treatment for the adverse events. The outcome of the events was recovered in Jan2021.

Other Meds: JUNEL FE; LEXAPRO

Current Illness:

ID: 0951988
Sex: F
Age:
State: GA

Vax Date: 12/23/2020
Onset Date: 12/24/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore arm; This is a spontaneous report from a contactable other health care professional. A 23-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EJI685), intramuscular on 23Dec2020 04:00 at single dose at arm right for COVID-19 immunization. The patient's medical history was reported as none. Concomitant medications included sertraline hydrochloride (ZOLOFT), and desvenlafaxine succinate (PRISTIQ). On 24Dec2020 08:00, the patient experienced sore arm. The patient did not receive treatment for the event. The outcome of the event was recovered.

Other Meds: ZOLOFT; PRISTIQ

Current Illness:

ID: 0951989
Sex: F
Age:
State: WA

Vax Date: 12/19/2020
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Name: Fever; Result Unstructured Data: Test Result:99.9; Test Name: COVID 19 test; Test Result: Negative ; Test Name: COVID 19 test; Test Result: Negative

Allergies:

Symptoms: Mild fatigue; Sore arm; Body aches; Had a tickle in her throat; Had a mild come and go headache; He had a Fever of 100.5, but hers was only 99.9; Exposure to COVID; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Dec2020 at single dose for covid-19 immunization. There were no medical history or concomitant medications. The patient experienced mild fatigue, sore arm, body aches, had a tickle in her throat, had a mild come and go headache, "he had a fever of 100.5, but hers was only 99.9", and exposure to covid on an unspecified date. Event details: The patient received the first COVID vaccine on 19Dec2020, through work. She did really well with it. She had mild fatigue, but she also worked for 12 hours so it was hard to tell if it was from that or working. She did have a sore arm like from getting a tetanus shot. At the beginning of this week, her boyfriend got COVID symptoms on Monday, and tested positive. On Monday, she had mild COVID symptoms as well. He had a Fever of 100.5, but hers was only 99.9. She had body aches, and her arms were sore like she did bicep exercises. She had a tickle in her throat. She has had a mild come and go headache. Her boyfriend has had all the symptoms. She has tested negative for COVID twice. She worked with two different ERs. One was saying she was presumed positive, and must be out of work / on quarantine a month. The other one said it could be because of the vaccine. The one who was telling her to have an extensive quarantine was supposed to give her the second vaccine on 07Jan2021, yesterday. The other says she shouldn't get the second dose of the vaccine any way if she was sick. She felt like she was fine. She didn't think this was the vaccine. She thought it was COVID exposure, and she just had mild symptoms and a negative test because she had the vaccine. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0951990
Sex: F
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: 3 days of very bad headache; This is a spontaneous report received from a contactable consumer (patient). A 43-year-old female patient received BNT162B2 (BIONTECH COVID-19 VACCINE lot number and expiry date not reported), via an unspecified route of administration in left arm, on 09Jan2021 19:00, at single dose, for COVID-19 immunization. Medical history included food allergies. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. The patient did not receive any other vaccines in four weeks. The patient experienced 3 days of very bad headache on 10Jan2021 at 08:00. No treatment was received for the event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0951991
Sex: F
Age:
State: CO

Vax Date: 01/08/2021
Onset Date: 01/10/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Soreness at injection site Supraclavicular lymphadenopathy on side of injection; Soreness at injection site Supraclavicular lymphadenopathy on side of injection; This is a spontaneous report from a non-contactable other health care professional (patient). A 39-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3249 and expiration date not provided), via an unspecified route of administration (arm left) second dose on 08Jan2021 17:15 at single dose for COVID-19 immunisation. The patient's medical history was not reported. The patient's concomitant medications included venlafaxine and levothyroxine. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020 for covid-19 immunisation (first dose, left arm, lot number EH9899). On 10Jan2021, the patient experienced Soreness at injection site, Supraclavicular lymphadenopathy on side of injection. No treatment was given. The outcome of the events was unknown. Facility where the most recent COVID-19 vaccine was administered was in the Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No follow-up attempts are possible. No further information is expected.

Other Meds: ;

Current Illness:

ID: 0951992
Sex: F
Age:
State: VA

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: anaphylactic reaction/anaphylaxis; This is a spontaneous report from a Pfizer Sponsored Program from a contactable pharmacist. A female patient of an unspecified age received first dose of bnt162b2 (Pfizer BioNTech COVID vaccine, lot number: EK4176), via an unspecified route of administration on 09Jan2021 at 0.3 mL, single (standard like 0.3ml by injection once to deltoid, side unknown) to prevent from getting COVID. The patient's medical history and concomitant medications were not reported. The patient experienced anaphylactic reaction/anaphylaxis on 09Jan2021. Clinical course: The patient got the vaccine while waiting to go into the watch room, to be watched for a few minutes, and she experienced anaphylactic reaction/anaphylaxis, she went down, they gave her an Epinephrine, she didn't respond to the first dose, a second dose was given in the arm where the vaccine was given, then she was picked up by an ambulance. Agent stated the caller has been on hold for almost an hour. Caller clarifies dose was given in the arm, it occurred on Saturday with the same lot. Saturday and it went away on Saturday, the patient was worried about it coming back, thus why she asked about Epinephrine pen, the patient was taken to the hospital, and given Epinephrine a couple more times, and it resolved eventually, the patient was not admitted, she went to the Emergency Department. It could have required hospitalization but would most likely say life threatening had she not been treated. Reporter seriousness for anaphylaxis is life threatening. The outcome of event was recovered on 09Jan2021. Relatedness of bnt162b2 to reaction anaphylaxis is related for primary source.; Sender's Comments: A possible causal association between administration of BNT162B2 and the onset anaphylactic reaction/anaphylaxis cannot be excluded, considering the plausible temporal relationship and the known adverse event profile of the suspect product. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0951993
Sex: F
Age:
State: PA

Vax Date: 01/05/2021
Onset Date: 01/06/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Pending

Allergies:

Symptoms: Fever for 5 days; rash on neck; body aches; sore throat; bloody nose; cough; fatigue; This is a spontaneous report from a contactable nurse. A 43-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscularly on 05Jan2021 08:00 at single dose for COVID-19 immunization. The patient medical history was not reported. No known allergies. Concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), zolpidem tartrate (AMBIEN), cyanocobalamin (B12), lamotrigine (LAMICTAL), paracetamol (TYLENOL), vilazodone hydrochloride (VIIBRYD), colecalciferol (VITAMIN D). The patient experienced fever for 5 days, rash on neck, body aches, sore throat, bloody nose, cough, fatigue, all on 06Jan2021 04:00. The adverse events resulted in Emergency room/department or urgent care. No treatment received. This is a non-serious repot. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19: Nasal Swab on 08Jan2021, test name: PCR, pending result. The outcome of the events was recovering. Information on the lot/batch number has been requested.

Other Meds: ADDERALL; AMBIEN; B12; LAMICTAL; TYLENOL; VIIBRYD; VITAMIN D

Current Illness:

ID: 0951994
Sex: F
Age:
State: KY

Vax Date: 01/02/2021
Onset Date: 01/02/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Date: 20210103; Test Name: fever; Result Unstructured Data: Test Result:100.5

Allergies:

Symptoms: the muscle was very tight and stiff; the muscle was very tight and stiff; fatigued; a fever of 100.5 developed; my arm was very sore; This is a spontaneous report from a non-contactable nurse (patient). A 25-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration in the right arm on 02Jan2021 11:15 at single dose for COVID-19 immunization. There was no medical history. The patient has no known allergies. The patient was not pregnant. The patient's concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient got the vaccine Saturday, by 1500 her arm was very sore. Sunday morning her arm was so sore she could hardly move it the muscle was very tight and stiff. She was also very fatigued all day Sunday (03Jan2021) and slept most of the day, a fever of 100.5 developed. When she woke up Monday morning the fever was gone, fatigue was gone and the soreness in her arm felt like normal soreness after a vaccine such as the flu vaccine. Come Wednesday her arm was finally not sore anymore. The patient did not received treatment for the events. The outcome of the events was recovered on Jan2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0951995
Sex: F
Age:
State: NC

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: Blood pressure; Result Unstructured Data: Test Result:126/68; Test Date: 202101; Test Name: pulse; Result Unstructured Data: Test Result:81

Allergies:

Symptoms: She has one big toe that is arthritic and it does not seem to want to bend; More like her balance does not feel right/Still feels a little off kilter; Dizziness; Hard time focusing her sight; Neck and toe stiffness; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in right arm on 06Jan2021 around 13:00-14:00 at single dose for covid-19 immunization. There were no medical history or concomitant medications. The patient got the vaccine this week on 06Jan2021 right after lunch/early afternoon. She had no issues. In the afternoon of 07Jan2021, she started getting a little dizzy and had a hard time focusing her sight. The patient also had neck and toe stiffness on 07Jan2021. She did not think about the vaccine until last evening of 07Jan2021. The hospital called to see how she was doing, and then it dawned on her. After, she took her blood pressure which was 126/68 with 81 pulse. She slept well last night of 07Jan2021. This morning on 08Jan2021 she had breakfast but still felt a little off kilter. It is like dizziness, not really dizzy, but more like her balance does not feel right. She was focusing better on 08Jan2021, but not like normal. The dizziness hit her on 07Jan2021 about 15:00. It had improved. She felt more at the time of the report, not really dizzy, but more like her balance did not feel right. It was earlier on 07Jan2021 around 14:00 she was on the ladder taking down her Christmas bows. She had no dizziness whatsoever. For neck and toes stiffness, she had one big toe that was arthritic and it did not seem to want to bend. She had been doing neck exercises which had helped. The outcome of dizziness, hard time focusing her sight, neck and toe stiffness were resolving, outcome of rest events were unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0951996
Sex: F
Age:
State: CO

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: severe headache; nausea; chills; sinus pain; cough; joint pain; Bedridden; Arm still sore at 60 hours; This is a spontaneous report from a contactable other Health Professional (patient). A 64-year-old non-pregnant female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number= EH9899), via an unspecified route of administration on 07Jan2021 10:30 at single dose in right arm for covid-19 immunization. Medical history included hypertension (Htn), chronic kidney disease (CKD), the patient had known allergies to ibuprofen, bee stings. The patient previously took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EH9899), on 17Dec2020 at the single dose for covid-19 immunization and experienced very sore arm. Concomitant medications the patient received within 2 weeks of vaccination reported as yes. The patient experienced severe headache, nausea, chills, sinus pain, cough, and joint pain for 24 hrs; headache and nausea continued another 12 hours. Bedridden first 24 hours. Arm still sore at 60 hours on 07Jan2021 22:00. The patient did not receive any treatments. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0951997
Sex: M
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/01/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Flu-like symptoms started at 12 hours post injection of 2nd dose.; severe body aches; shivering; significant fatigue; This is a spontaneous report from a non-contactable physician (patient). A 37-year-old male patient started to received the second dose of bnt162b2 (COVID 19 vaccine, brand: Pfizer) lot no: EK9231, intramuscular in left arm on 06Jan2021 at single dose for COVID-19 immunization in a hospital. Medical history included asthma from an unknown date and unknown if ongoing. No known allergies. The patient's concomitant medications were not reported. The patient previously received the first dose of bnt162b2, lot no: EH9899, on 18Dec2020 intramuscularly in left arm for immunization. No other vaccines were administered in four weeks. The patient had no COVID-19 prior to vaccination was not tested for COVID-19 post vaccination. The patient experienced flu-like symptoms started at 12 hours post injection of 2nd dose. Started with severe body aches, then shivering and significant fatigue. The patient improved only a little with paracetamol (TYLENOL). After 24 hours symptoms onset, symptoms mostly resolved. The adverse events were reported as non-serious. The patient recovered from the events. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0951998
Sex: F
Age:
State: CA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Name: temparature; Result Unstructured Data: Test Result:99.5 c

Allergies:

Symptoms: severe aching hands/severe arm pain; feet like arthritis bad day after vaccine; Low grade fever 99.5 c; This is a spontaneous report from a contactable Physician .This Physician reported different events for 2 doses. This case is for 2nd dose. The 40-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), at left arm on 08Jan2021 at SINGLE DOSE for COVID-19 immunization. She received the first dose on 17Dec2020 8:00 AM at right arm at single dose Lot number#Ej1685 and she had flare a week after first vaccine with mild foot swelling but severe leg and foot pain.Medical history included Possible asthma and left foot post traumatic arthritis with multiple surgeries including precious allograph, meralgia parasthetica left side. The patient is not pregnant. No COVID prior vaccination. Facility where the most recent COVID-19 vaccine was administered was hospital.The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. None Concomitant medications (received within 2 weeks of vaccination) .No known allergies. . After second vaccine severe aching hands, feet like arthritis bad day after vaccine. Low grade fever 99.5 c. No treatment received for the events. The events were assessed as non-serious. The patient had not been tested for COVID post vaccination. The outcome of the events was recovering on unspecified date. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0951999
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Felt bad after their 2nd Covid 19 Pfizer vaccine; This is a spontaneous report from a non-contactable nurse via Pfizer sales representative. A female patient of an unspecified age received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient felt bad after their second Pfizer vaccine. It was not unexpected. Outcome of the event was unknown. No follow up attempts are possible. Information about lot and batch number could not be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0952000
Sex: F
Age:
State: CO

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Extreme fatigue; Uncontrollable chills for 3 hours; Flu like symptoms; Generalized muscle soreness; Stuffy nose and ears; Stuffy nose and ears; Short of breath; Loss of appetite; Headache; Headache; This is a spontaneous report from a contactable nurse (patient). A 35-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK9231), via an unspecified route of administration on 08Jan2021 07:15 at right arm, at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EJ1685), via an unspecified route of administration on 28Dec2020 at right arm, at single dose for covid-19 immunization, and experienced mild headache and mild arm soreness. The patient received the second dose, and experienced extreme fatigue, uncontrollable chills for 3 hours, flu-like symptoms (headache, generalized muscle soreness, stuffy nose and ears), short of breath, loss of appetite, all at 08Jan2021 13:00. The outcome of the events was recovering. No treatment was received for all events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No seriousness criteria: no Results in death, no Life threatening, no Caused/prolonged hospitalization, no Disabling/Incapacitating, no Congenital anomaly/birth defect.

Other Meds:

Current Illness:

ID: 0952001
Sex: F
Age:
State: VA

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Date: 20210110; Test Name: fever; Result Unstructured Data: Test Result:100.2-101.0; Test Date: 20201026; Test Name: covid test/Rapid nasal swab; Test Result: Negative

Allergies:

Symptoms: profound headache; resembling meningitis: could not turn neck from side to side; resembling meningitis: could not turn neck from side to side; pressure behind eyes when moving eyes quickly; profound body aches, primarily in the lower back; profound body aches, primarily in the lower back; 100.2-101.0 fever; chills; lethargy; This is a spontaneous report from a contactable Nurse reported for self. A 27-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot#: EL1284), via an unspecified route of administration in left arm on 09Jan2021 18:30 at single dose for covid-19 immunisation. Medical history was not reported. Concomitant medication included influenza vaccine inact split 4v (AFLURIA QUAD), desogestrel, ethinylestradiol (APRI). The patient experienced profound headache, resembling meningitis: could not turn neck from side to side, pressure behind eyes when moving eyes quickly. -profound body aches, primarily in the lower back. -100.2-101.0 fever -chills -lethargy on 10Jan2021 12:00. Patient had Rapid nasal swab with negative result on 26Oct2020. Outcome of events was recovering.

Other Meds: APRI

Current Illness:

ID: 0952002
Sex: F
Age:
State: CA

Vax Date: 12/30/2020
Onset Date: 01/08/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Enlarged lymph node under left armpit (site of injection); This is a spontaneous report from a contactable consumer (patient). A 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: not reported), via an unspecified route of administration on 30Dec2020 at a single dose on the left arm (reported as left armpit) for COVID-19 immunization in a hospital. Medical history was reported as none. The patient has no allergies to medications, food, or other products. The patient was not diagnosed with COVID-19 prior to vaccination. The patient received an unspecified birth control within two weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 08Jan2021, the patient experienced enlarged lymph node under left armpit (site of injection). The patient was not given any treatment for the event. Since the vaccination, the patient has not been tested for COVID-19. The patient was not pregnant at the time of vaccination. The outcome of the event was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0952003
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headache; fever; myalgia; arthralgia; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sales representative. A 29-year-old female patient received their second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received their first dose of BNT162B2 on an unspecified date for COVID-19 immunization. The patient experienced headache, fever, myalgia and arthralgia on an unspecified date. The outcome of the events was unknown. No follow-up attempts are possible. Information about Lot/Batch could not be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0952004
Sex: F
Age:
State: NV

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Name: Weight; Result Unstructured Data: Test Result:between 130lbs and 140lbs lbs

Allergies:

Symptoms: Very sore arm with first COVID-19 Vaccine; This is a spontaneous report from a contactable nurse (patient). A 50-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EH9899) via an unspecified route of administration on the left arm on an unspecified date at a single dose for COVID-19 immunization. The patient had no medical history. Family medical history of high blood pressure. There were no concomitant medications. On an unspecified date, the patient experienced very sore arm with first COVID-19 Vaccine. Patient stayed home, didn't go to primary. Her weight was between 130lbs and 140lbs. There were no additional vaccines administered on same date of Pfizer suspect. No relevant tests done. Outcome of the event was unknown.

Other Meds:

Current Illness:

ID: 0952005
Sex: F
Age:
State:

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Vomiting; This is a spontaneous report from a non-contactable nurse (patient). A 32-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EK9231), via an unspecified route of administration in left arm, on 07Jan2021, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered in a hospital. On 07Jan2021, the patient started vomiting 12 hours after injection. The event was considered non-serious. No treatment was received for the adverse event. Since the vaccination, the patient has not been tested for COVID-19. The patient was recovering from the event. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0952006
Sex: F
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sore arm; painful stiff neck; painful stiff neck; chills; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age started received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot and expiration date unknown), via an unspecified route of administration on 09Jan2021 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 10Jan2021, the patient experienced sore arm, painful stiff neck, and chills. Patient could not lift arm above shoulder height or turn head. At the time of report, still have some neck pain but better than yesterday. Patient was able to turn head today. No chills and arm was still sore. The outcome of the event sore arm was not recovered, painful stiff neck was recovering and recovered from the event chills. No follow-up attempts are possible; information about batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0952007
Sex: F
Age:
State:

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: temp; Result Unstructured Data: Test Result:feverish (but no elevated temp)

Allergies:

Symptoms: Tired; Headache; Feverish; Eyes felt allergy like; Lips felt chapped; This is a spontaneous report from a contactable consumer (patient herself). A female patient of an unspecified age received a second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 07Jan2021 at a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (lot number and expiry date not reported) at single dose for COVID-19 immunisation. On 08Jan2021, the patient was tired, had headache, was feverish (but not elevated temp), eyes felt allergy like, and lips felt chapped. All were mild. Clinical outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm